Conditioning regimen with BCNU, etoposide, cytarabine and melphalan plus amifostine for outpatient autologous stem cell transplant: feasibility and outcome in 97 patients with lymphoma

Leuk Lymphoma. 2014 Jul;55(7):1657-60. doi: 10.3109/10428194.2013.842989. Epub 2013 Nov 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amifostine / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carmustine / administration & dosage
  • Cytarabine / administration & dosage
  • Etoposide / administration & dosage
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lymphoma / therapy*
  • Melphalan / administration & dosage
  • Outpatients
  • Transplantation Conditioning*
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Cytarabine
  • Etoposide
  • Amifostine
  • Melphalan
  • Carmustine